Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 4/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 2/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22370920 | 1.00 | CYP2D6 (0.36) | CYP2D6CYP2C19GABRR1CACNA2D1CACNB3 | |
| SCHEMBL15543175 | 1.00 | CYP2D6 (0.36) | CYP2D6CYP2C19GABRR1CACNA2D1CACNB3 | |
| SCHEMBL7424883 | 0.81 | ALDH1A1 (0.39) | CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C | |
| SCHEMBL19285493 | 0.80 | GABRR1 (0.32) | GABRR1 | |
| SCHEMBL20495048 | 0.80 | GABRR1 (0.32) | GABRR1 | |
| SCHEMBL6722400 | 0.78 | TAS1R3 (0.42) | CYP2D6CYP2C19CA1CA2CA7 | |
| SCHEMBL1261511 | 0.78 | CNR1 (0.39) | CYP2D6CYP2C19CA1CA2CA7 | |
| SCHEMBL16648831 | 0.78 | CNR1 (0.39) | CYP2D6CYP2C19CA1CA2CA7 | |
| SCHEMBL1120240 | 0.78 | CNR1 (0.39) | CYP2D6CYP2C19CA1CA2CA7 | |
| SCHEMBL21047206 | 0.77 | ECE1 (0.42) | CYP2D6CYP2C19CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395259-A1 | CDK INHIBITORS | G1 THERAPEUTICS, INC. (US) | 2021-12-23 | — | — | US | disclosed |
| US-10927120-B2 | CDK inhibitors | GI Therapeutics, Inc. (NC) | 2021-02-23 | — | — | US | disclosed |
| US-20200277300-A1 | CDK INHIBITORS | G1 THERAPEUTICS, INC. (US) | 2020-09-03 | — | — | US | disclosed |
| CN-1984880-B | Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient | MITSUI CHEMICALS INC | 2010-09-22 | — | — | CN | disclosed |
| CN-1984880-A | Diamine derivative, process for producing the same, and fungicide containing the same as active ingredient | MITSUI CHEMICALS INC (JP) | 2007-06-20 | — | — | CN | disclosed |
| US-20070066586-A1 | ANILINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1736465-A1 | ANILINE DERIVATIVES | Ajinomoto Co., Inc. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395259-A1 | CDK INHIBITORS | CDK3, CDK9, CDK6 | CYP2D6 640/4885CYP2C19 436/4885GABRR1 4396/4885 |
| US-20200277300-A1 | CDK INHIBITORS | CDK3, CDK9, CDK6 | CYP2D6 640/4885CYP2C19 436/4885GABRR1 4396/4885 |
| US-10927120-B2 | CDK inhibitors | CDK3, CDK9, CDK6 | CYP2D6 640/4885CYP2C19 436/4885GABRR1 4396/4885 |
| US-20070066586-A1 | ANILINE DERIVATIVES | SERPINB1, ACE, REN | CYP2D6 369/4885CYP2C19 172/4885GABRR1 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.